Application 212088
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | TABLET, DELAYED RELEASE;ORAL | EQ 20MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212088-001 | ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE / ORAL | 2020-06-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212088-001 | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE / ORAL | 2020-06-25 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acid Reducer | ESOMEPRAZOLE MAGNESIUM | Walgreens | 4f3c1d76-e1ba-4f85-9384-ed8f35fa6bc6 | 2026-03-25 | Warnings | 212088 ANDA212088 0363-9977 |
| Acid Reducer | ESOMEPRAZOLE MAGNESIUM | CVS Pharmacy | 001817ea-906e-47f7-8605-41ba5a9abd21 | 2026-01-21 | Warnings | 212088 ANDA212088 69842-679 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0363-9977 | Acid Reducer | Esomeprazole magnesium | Walgreens | ANDA | Current |
| 11822-5600 | Acid Reducer | Esomeprazole magnesium | Rite Aid Corporation | ANDA | Current |
| 11822-5600 | Acid Reducer | Esomeprazole magnesium | Rite Aid Corporation | ANDA | Current |
| 11822-5600 | Acid Reducer | Esomeprazole magnesium | Rite Aid Corporation | ANDA | Current |
| 37808-856 | Acid Reducer | Esomeprazole magnesium | H E B | ANDA | Current |
| 59726-056 | Acid Reducer | Esomeprazole magnesium | P & L Development, LLC | ANDA | Current |
| 59726-056 | Acid Reducer | Esomeprazole magnesium | P & L Development, LLC | ANDA | Current |
| 69842-679 | Acid Reducer | Esomeprazole magnesium | CVS Pharmacy | ANDA | Current |
| 69842-679 | Acid Reducer | Esomeprazole magnesium | CVS Pharmacy | ANDA | Current |
| 70000-0095 | Acid Reducer | Esomeprazole magnesium | Cardinal Health (Leader) 70000 | ANDA | Current |
| 70000-0095 | Acid Reducer | Esomeprazole magnesium | Cardinal Health (Leader) 70000 | ANDA | Current |
| 70000-0095 | Acid Reducer | Esomeprazole magnesium | Cardinal Health (Leader) 70000 | ANDA | Current |